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http://www.biomedcentral.com/1471-2164/15/830RESEARCH ARTICLE Open AccessComparative genome analysis identifies few traits
unique to the Escherichia coli ST131 H30Rx clade
and extensive mosaicism at the capsule locus
Abdulaziz Alqasim1, Fleming Scheutz2, Zhiyong Zong3 and Alan McNally1*Abstract
Background: E.coli ST131 is a globally disseminated clone of multi-drug resistant E. coli responsible for that vast
majority of global extra-intestinal E. coli infections. Recent global genomic epidemiological studies have highlighted
the highly clonal nature of this group of bacteria, however there appears to be inconsistency in some phenotypes
associated with the clone, in particular capsule types as determined by K-antigen testing both biochemically and
by PCR.
Results: We performed improved quality assemblies on ten ST131 genomes previously sequenced by our group
and compared them to a new reference genome sequence JJ1886 to identify the capsule loci across the
drug-resistant clone H30Rx. Our data shows considerable genetic diversity within the capsule locus of H30Rx clone
strains which is mirrored by classical K antigen testing. The varying capsule locus types appear to be randomly
distributed across the H30Rx phylogeny suggesting multiple recombination events at this locus, but that this
capsule heterogeneity has little to no effect on virulence associated phenotypes in vitro.
Conclusions: Our data provides a framework for determining the capsular genetics of E. coli ST131 and further
beyond to ExPEC strains, and highlights how capsular mosaicism may be an important strategy in becoming a
successful globally disseminated human pathogen.
Keywords: E. coli ST131, Comparative genomics, Capsule, RecombinationBackground
Extra-intestinal pathogenic Escherichia coli (ExPEC) in-
fections are one of the leading causes of morbidity in
the developed world and are particularly associated with
infections of the urinary tract (UTI) and with bacter-
aemia. In recent years one particular clone of ExPEC has
emerged to become a globally dominant cause of human
infection, E. coli ST131 ([1] which is also associated with
the emergence and spread of multiple-drug resistance in
ExPEC infections via the sustained carriage of the CTX-
M-15 extended spectrum beta-lactamase enzyme [2].
Recent work has focussed on elucidating the genomic
epidemiology of this group of organisms since the report
of the genetically homogeneous nature of clinically un-
related isolates in 2012 [3]. Two independent studies* Correspondence: alan.mcnally@ntu.ac.uk
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unless otherwise stated.identified that all CTX-M-15 positive isolates belonged
to a single expanded clone which emerged some time
previous to 2000 [4,5] and which is now referred to as
the H30Rx clade of E. coli ST131 [4]. Both studies show
this clade to be monomorphic containing a few dozen
SNPs difference in data sets spanning geographical and
temporal space.
The genetic architecture of the H30Rx clade was also
examined [5], paying particular attention to virulence as-
sociated genes of ExPEC and to mobile genetic elements
not found in non-ST131 ExPEC. In general these data
suggested no ST131 specific virulence gene repertoire as
such, though did highlight the seemingly unique nature
of the second flagellar cluster Flag-2, which had been
previously identified in E. coli ST131 genomes [3,6].
Additionally the analysis also highlighted the role of
intra-ST131 recombination in shaping the lineage [5]
and identified a recombinant fragment common across
ST131 within the capsule locus. Classical capsular typingl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 List of strains and genomes used in this study
Strain ST Pathotype Accession number
E. coli UTI18 131 ExPEC ERP001095
E. coli EC958 131 ExPEC CAFL01000001
E. coli NA114 131 ExPEC CP002797.1
E. coli UTI24 131 ExPEC ERP001095
E. coli UTI32 131 ExPEC ERP001095
E. coli UTI62 131 ExPEC ERP001095
E. coli UTI188 131 ExPEC ERP001095
E. coli UTI226 131 ExPEC ERP001095
E. coli UTI306 131 ExPEC ERP001095
E. coli UTI423 131 ExPEC ERP001095
E. coli UTI587 131 ExPEC ERP001095
E. coli UTI570 131 ExPEC ERP001095
E. coli JIE168 131 ExPEC ERP001095
E. coli JJ1886 131 ExPEC CP006784.1
E. coli SE15 131 Human commensal AP009378.1
E. coli LF82 135 AIEC NC_011993.1
E. coli IHE3034 95 ST95 ExPEC CP001969.1
E. coli UTI89 95 ST95 ExPEC CP000243.1
E. coli S88 95 O45 ExPEC CU928161.2
E. coli APEC01 95 APEC CP000468.1
E. coli UM146 643 AIEC CP002167.1
E. coli NRG857c 135 AIEC CP001855.1
E. coli ED1a 452 O81 CU928162.2
ABU89372 73 Asymptomatic CP001671
E. coli CFT073 73 ExPEC AE014075.1
E. coli Di14 73 ExPEC AE014075.1
E. coli Di12 73 ExPEC CP002211.1
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were in the H30Rx clade, has shown high diversity in the
biochemical profile of capsule antigens [7] which seems
surprising given the monomorphic nature of the H30Rx
clade. There were a total of 7 different K capsule types
identified within the forty four ST131 isolates tested,
which is in contrast to the vast majority of capsule typing
which had been performed previously on E. coli ST131
using PCR based methods and which predominantly iden-
tified K2 type capsules via kpsMII primers [8,9]. Indeed
none of the strains biochemically tested were identi-
fied as K2 but rather as K100 despite testing K2 posi-
tive by PCR [7].
Given that the comparative genomics performed to date
on E. coli ST131 have focussed on virulence associated
genes, and the confusing data available to date on the di-
versity of the capsule locus, we sought to investigate loci
uniquely associated with the H30Rx clade of E. coli ST131
using previously published genomes [3,6,10,11]. We ana-
lysed a pangenome created from our ST131 genomes
against reference non-ST131 ExPEC genomes to identify a
small number of loci unique to ST131 dominated by
lineage unique phages and the Flag-2 locus. Additionally
we provide a genetic architecture for the diversity ob-
served in the capsule locus of ST131, and show extensive
genetic and biochemical diversity of the capsule region
even within the H30Rx lineage of ST131. The random
phylogenetic dispersal of these capsule loci suggests re-
combination occurs frequently at this region within
ST131 and concurs with the previous suggestion that
the capsule locus may be coming under strong select-
ive pressure in the lifestyle of E. coli ST131 H30Rx [5].
Results and Discussion
Identification of genetic loci unique to the E. coli ST131
H30Rx clade
Given the focus on virulence associated genes in previous
gene content studies, we aimed to determine loci unique
to ST131 isolates without bias for functionality of the en-
coding loci. An ExPEC pan genome was constructed using
the blast-score ratio method implemented in LS-BSR [12]
containing twelve ST131 genomes and all available non-
ST131 reference genome sequences (Table 1). Using the
resulting pan-genome matrix we determined the genetic
loci uniquely associated with the ST131 group versus the
non-ST131 group using the compare_BSR python script
implemented in the LS-BSR package. To define the ST131
group we excluded NA114 on the basis that previous work
has suggested the methodology used to assemble the gen-
ome has resulted in regions missing from that genome
that are present in all other H30Rx strains [5]. We also
ran the analysis with SE15 as an ST131 but non-H30Rx
strain to determine loci unique to the H30Rx clade to
which SE15 does not belong [5,13]. Our resulting dataset identified a total of 150 loci unique to ST131 H30Rx
strains in comparison to other ExPEC (Additional file 1),
dominated by three phages common across the lineage
and which have most probably been acquired by the com-
mon ancestral H30Rx progenitor and then maintained in
the lineage. Hypothetical proteins dominate the functional
category of genes (Figure 1) followed by flagellar associ-
ated genes and then a small number of metabolic loci.
These metabolic loci correlate with data previously pub-
lished by our group and add further weight to the asser-
tion that ST131 H30Rx is not a metabolically distinct
lineage [14]. The most striking locus with respect to po-
tential biology is the confirmation that the Flag-2 ac-
cessory flagella locus is unique to ST131 H30Rx amongst
ExPEC strains [5]. Again it is likely that this is ancestral to
the H30Rx clade but its acquisition within the larger
ST131 lineage is suggestive of a possible role in the forma-
tion and dissemination of the H30Rx clade and merits a
fuller bacterial genetics investigation of its importance and
Figure 1 Functional categories of genes unique to E. coli ST131 within the ExPEC pathotype. Graph showing the distribution of functional
categories for genes unique to the E. coli ST131 H30Rx compared to a collection of ExPEC reference genomes. Unique loci were identified by
creating a pan genome of all genomes in Table 1, and then using the compare_bsr script in LS-BSR to identify loci unique to the ST131
H30Rx strains.
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tion of all of the H30Rx loci identified as clade associated
may be of merit. A saturated transposon mutant library
has been constructed in an H30Rx strain and was utilised
to determine the essential gene set for serum resistance
[15]. Using such a library to test a wider set of environ-
mental and infection conditions would undoubtedly eluci-
date if the H30Rx unique loci do indeed play a formative
role in the success of the lineage.Genetic architecture of capsule locus variation in the
H30Rx clade
Given the reported variability of capsule loci [5] and
capsular antigen type [7] in E. coli ST131 H30Rx clade
strains, we investigated this locus in more detail. We se-
lected the recently released JJ1886 genome [10] as our
reference given it is the only ST131 genome sequenced
and assembled to a standard of quality commensurate
with being a high quality genome [16]. Using this refer-
ence we re-ordered the contigs of the ST131 genomes
previously reported by our group [3] to ensure the gen-
ome architecture was as accurate as possible. We then
identified the capsule loci of all of the ST131 genomes at
our disposal and created separate embl files for each
capsule locus of each strain which we then compared
using EasyFig [17]. The comparison of the capsule loci
(Figure 2) shows a high degree of diversity between the
conserved kpsS and kpsTM regions, with no observable
similarity between strains in the variable central genes.
Blast analysis of each of the variable central genes in
each genetic capsule type present returned no significant
hits with any reference E. coli sequences. To ascertainhow this genetic architecture reflected upon biochemical
typing we determined the K antigen type of each of the
genetic capsule types for strains which were in our pos-
session by classical capsule typing (Figure 2), and also
overlaid any available capsule type information on the
other sequenced strains. Our data shows a correlation
between the genetic capsular type and the biochemical
typing data, and provides a framework for which to con-
textualise E. coli capsule types from genomic data. More
importantly for this study our data clearly shows signifi-
cant diversity within the capsule locus in E. coli ST131
H30Rx strains suggestive of frequent and targeted re-
combination in this region [5].
To examine this in more detail we created a core gen-
ome phylogeny for E. coli ST131 using all the ST131
genome sequences in Table 1 and previously published
methodology [13,18] using SE15 as the root of the phyl-
ogeny given its phylogenetic position relative to H30Rx
[5]. The resulting phylogenetic tree (Figure 3) confirms
that all but one of the strains in our analysis, including
those previously sequenced by our group prior to the
discovery of H30Rx [3] do indeed belong the H30Rx
clade. More importantly when the capsule loci genetics
were superimposed on the phylogenetic tree it clearly
demonstrates that the capsule loci are randomly distrib-
uted across the phylogeny. The only exceptions to this
are the small cluster of strains containing UTI18 which
have been previously shown by us to essentially be a sin-
gle clone [3]. Such a random dispersal of the capsule loci
across the phylogenetic tree can only be explained by ex-
tensive and targeted recombination events at this dis-
creet location on the genome, suggesting there is some
pressure acting on the capsule locus resulting in constant
Figure 2 Capsule locus genetics of a collection of E. coli ST131 H30Rx genomes. Figure showing all of the capsule loci identified in
available E. coli ST131 genomes. The CDS marked in green are the kpsF-E-D-UC-S cluster, and those in red the kpsT-M cluster, both of which are
highly conserved across all E. coli capsules. The CDS marked in cyan are unique CDS to that capsule type. The grey shading indicates the level of
identity between any given pair of CDS. The K antigen identified for each genetic capsule type is indicated in letters to the left, whilst the strain
the capsule locus belongs to is indicated by letters to the right.
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Such extensive recombination has been well characterised
in Streptococcus pneumonia where capsule locus switching
has been shown to play a significant role in vaccine escape
[19] and in the evolutionary dynamics of densely popu-
lated infection foci [20], however such dynamism in cap-
sular recombination in E. coli is hitherto uncharacterisedparticularly in such a genetically monomorphic clade as
ST131 H30Rx.
Capsule diversity has no obvious effect on virulence
associated phenotypes in vitro
Given the observation of extensive recombination at the
capsule region of the H30Rx clade we sought to determine
Figure 3 Phylogenetic distribution of K-antigen types in E. coli ST131 H30Rx. Core-genome phylogeny of the E. coli ST131 genomes
analysed in this study, with the SE15 strain included as an outlier. The H30Rx strains are indicated by red colouration of tree branches. The
Nottingham “outbreak” strains previously sequenced by our group are indicated by cyan colouration of the tree branches. The K-antigen type
and accompanying capsule locus genetics are superimposed to the right of the tree.
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of our ST131 strains to form capsules at 25°C and 37°C on
LB and CLED agar plates over a 14 day period. There was
no association with the capsule loci present in the differ-
ent H30Rx strains and levels of capsulation morphology
on agar plates (Table 2). Classical 96 well plate biofilm for-
mation assays also failed to show any significant pattern
between different H30Rx capsular variants. We also con-
ducted in vitro cell adhesion and invasion assays on T24
bladder epithelial cells using both the gentamicin protec-
tion assay to quantitate invasion, as well as confocal mi-
croscopy using strains carrying a medium copy numberTable 2 Results of capsule-associated phenotype tests for a s
Strain Capsule formation Biofilm Invasion of
T24 cells
Serum
37°C 25°C 37°C T0
UTI18 +++ +++ + ++ 7.67E +
UTI24 +++ +++ ++ + 1.00E +
UTI32 ++++ +++ + +++ 3.67E +
UTI62 ++ ++ + + 6.50E +
UTI188 ++ ++ + ++ 5.67E +
UTI226 +++ ++ +++++ ++ 4.17E +
UTI306 +++ +++ + +++ 2.00E +
UTI423 +++ +++ ++ ++++ 1.83E +
UTI570 ++ ++ +++++ ++ 1.00E +
UTI587 ++ ++ ++ ++ 4.33E +
Phenotype results are presented as an arbitrary score of: + low phenotypic expressiGFP+ containing plasmid [21]. As with our other virulence
associated phenotypes there was no associated difference
between different capsular variants of H30Rx. An identical
pattern was also observed when the ability of the strains
to survive inside cultured U937 macrophage like cell lines
was assayed. Finally we determined the levels of serum re-
sistance in our strains using methods previously employed
in our lab [22,23]. We found that the presence of different
capsular variants had no effect on serum resistance and
that all of our ST131 strains were totally resistant to
serum in the 3 hours used for our assay (Table 2). The im-
portance of serum resistance to E. coli ST131 has beenelection of E. coli ST131 strains
resistance Persistence in U937 Serotype
T3 T0 T24
06 1.17E + 08 2.44E + 05 8.56E + 04 O 25: K+: H-
07 1.50E + 08 3.67E + 05 1.33E + 04 O 25: K+: H-
06 1.17E + 08 2.89E + 05 1.66E + 04 O 25: K-: H 4
06 2.50E + 08 4.94E + 05 4.72E + 04 O 25: K+: H-
06 2.67E + 08 3.61E + 05 1.28E + 05 O 25:K 20, K 23:H 4
06 1.00E + 08 3.11E + 05 1.56E + 04 O 25: K 16: H-
06 1.50E + 08 4.72E + 05 1.00E + 04 O 25: K+: H-
06 1.50E + 08 2.78E + 05 4.33E + 04 O 25: K 5: H 4
07 1.17E + 08 4.22E + 05 2.17E + 04 NT
06 4.83E + 08 3.72E + 05 8.33E + 04 O 25: K+: H-
on, ++ medium phenotypic expression, +++ high phenotypic expression.
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eral glycosylation associated ORFs identified in as playing
an essential role in serum resistance. Capsules have clas-
sically been considered as important factors in the ability
of E. coli to survive human serum however our data sug-
gests that that capsule type may be less important, and
that the extensive capsular recombination demonstrated
in the ST131 H30Rx clade has no effect on the ability of
these pathogens to survive exposure to human serum. It
may be that the capsule variability alters phenotypes im-
portant for in vivo environments, and there may be merit
to future work investigating differences in infection dy-
namics between the capsule variants using appropriate
surrogate infection models.
Conclusions
E. coli ST131 is now the dominant causative agent of
extra-intestinal infection by E. coli in the developed world,
and is also heavily responsible for the increase in preva-
lence in multi-drug resistance in E. coli due to extended
carriage of the CTX-M-15 ESBL gene [1]. Recent exten-
sive genomic studies have led to a deep understanding of
the phylogeography of this lineage of ExPEC [4,5] and the
discovery of a sub-clade of ST131 which is globally dom-
inant and associated with the CTX-M-15 genotype which
has been termed the H30Rx clade [4]. Despite these exten-
sive studies the only efforts at comparative genomics of
the ST131 lineage have focussed solely on virulence asso-
ciated genes and large mobile genetic elements unique to
the lineage [5]. Here we present an approach where we
created an ExPEC pan-genome and then identified loci
uniquely associated with the ST131 H30Rx clade. Our
data is further suggestive that at a gene content level this
clade is rather unremarkable in comparison to other
ExPEC, as recently suggested for the clade at a metabolic
level [14], with the secondary flagellar locus Flag-2 the
stand-out region unique to ST131 within ExPEC. This re-
gion merits further detailed bacterial genetics analysis to
uncover its true importance to the emergence and success
of the H30Rx clade. Furthermore our analysis shows a sur-
prising level of diversity within the capsule locus of the
H30Rx clade with a phylogenetic distribution highly sug-
gestive of frequent recombination at the locus. This re-
combination has no obvious detectable effect on virulence
associated phenotypes in vitro. Given the level of diversity
observed at the capsule locus it is tempting to speculate
that there is significant selective pressure occurring at this
site during the life cycle of the H30Rx clade, and that
frequent recombination allows the clade to subvert that
pressure. This has been documented to occur in other
capsulated pathogens [20] and also ties in with previous
data from our group showing that ST131 strains did not
exhibit inter-species recombination across the E. coli spe-
cies but that rather recombination events were focussedwithin the ST131 lineage [13]. Temporal studies of ST131
populations from patients and environmental reservoirs
may allow us to determine if capsular switching does
occur in vivo and if it is an important mechanism in the
successful and prolonged dissemination of this important
human pathogen.
Methods
Strains and genome data
A list of genomes used in our study is provided in
Table 1, and of strains used in our study in Table 2. All
strains have been previously characterised [3,10,13,23]
with the exception of strain JIE186, which is an Australian
ST131 CTX-M-15 strain isolated in 2000, and has been
submitted to the ENA under our existing ST131 study ac-
cession number ERP001095.
Core and pan genome analysis
We created a pan genome for all ExPEC genomes in
Table 1 using LS-BSR [12]. We then used the compare_
BSR python script implemented in the LS-BSR package to
identify loci unique to genomes belonging to the H30Rx
clade, with the exception of NA114 which has been shown
to have known H30Rx genes missing from its assembly
[5]. The resulting 150 loci identified as H30Rx lineage
unique were identified by performing BlastX searches
against the genome of JJ1886 [10].
Identification of capsule loci in ST131 genomes
FastQ sequencing data for all of the ST131 genomes
produced by our group were re-assembled using Velvet
and PAGIT [24] and using JJ1886 as a reference genome
for contig re-ordering. This allowed us to re-order small
contigs to the capsule region. The genomes were then
annotated using Prokka [25] and the capsule regions
written to new embl files using Artemis. The capsule
encoding regions were visually compared using Easyfig
[17] and variable genes were searched against the non-
redundant database by BlastX search.
Classical capsule typing
Serotyping was done according to the method of Ørskov
and Ørskov. The K antigen was determined by counter-
current immunoelectrophoresis involving K-specific anti-
sera, except for the K1 and K5 antigens, which were
detected using K1- and K5-specific phages [7].
Whole genome phylogeny
All ST131 genomes were aligned using Mugsy [26] and
a core genome extracted as previously described [13,18].
Maximum likelihood phylogeny was determined using
RaxML [27] implementing the GTR-gamma model. The
resulting phylogeny was visualised using Figtree.
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Biofilm formation was performed at 37°C in static cul-
tures incubated for 5 days in both LB and BHI broth in
a 96 well plate, with 5 wells per strain. Assays were per-
formed on three independent occasions and values are
representative values of measured levels of crystal violet
retention as measured at A600. Capsule production was
determined using a scoring system through testing the
ability of each strain to form mucoid colonies in LB agar
and in CLED agar plates using two incubation tempera-
tures, 37°C and 25°C. Each strain was tested in triplicate.
Ability to invade T24 bladder epithelial cells was per-
formed as previously described [28], and also performed
with strains carrying a GFP+ containing plasmid pMN402
[21] which were visualised using confocal microscopy.
Serum resistance assays were performed as described pre-
viously [23], as were U937 macrophage cell line survival
assays [21].
Additional file
Additional file 1: Excel spreadsheet showing all of the loci
identified as unique to our E. coli ST131 strains by our pan-genome
analysis.
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